.Attributes Medicine, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Point of view calls for inclusion of people with MASLD and also dimension of liver end results in cardio-- kidney-- metabolic tests, when records propose mechanistically probable advantages and also professional protection-- and also summarizes points to consider for trial design as well as regulatory commendation.